• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PULMONX CORPORATION ZEPHYR ENDOBRONCHIAL VALVE (EBV)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PULMONX CORPORATION ZEPHYR ENDOBRONCHIAL VALVE (EBV) Back to Search Results
Model Number ZEPHYR 5.5-LP EBV
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Pleural Effusion (2010)
Event Date 05/20/2020
Event Type  Injury  
Manufacturer Narrative
Pleural effusion is a known, anticipated side effect associated with the zephyr valve treatment (criner et al.A multicenter randomized controlled trial of zephyr endobronchial valve treatment in heterogeneous emphysema (b)(6).Am j respir crit care med.2018; 198 (9): 1151-1164).In the (b)(6) study (ide clinical study used to support pma p180002's approval), 7.0% of the zephyr valve subjects and 0% of the control subjects experienced pleural effusion during the treatment period (less than or equal to 45 days).The zephyr ebv system ifu specifically references pleural effusion as a known side effect of this procedure.The reported event aligns with the experience observed in the (b)(6) clinical study and is an expected side effect of the zephyr valve treatment.The reported event was foreseeable and clinically acceptable in view of the expected patient benefit from the treatment.
 
Event Description
Patient underwent a bronchoscopic lung volume reduction (blvr) procedure with zephyr valves placed on (b)(6) 2020.The patient had mild pleural effusion which started on (b)(6)2020.The patient was hospitalized on (b)(6) 2020 and received an additional bronchoscopy on (b)(6) 2020.The pleural effusion was treated with puncture based on sonography and resolved on (b)(6) 2020.The patient was discharged from the hospital on (b)(6) 2020.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ZEPHYR ENDOBRONCHIAL VALVE (EBV)
Type of Device
ENDOBRONCHIAL VALVE
Manufacturer (Section D)
PULMONX CORPORATION
700 chesapeake drive
redwood city, ca
MDR Report Key10112876
MDR Text Key202093090
Report Number3007797756-2020-00124
Device Sequence Number1
Product Code NJK
UDI-Device Identifier00811907030423
UDI-Public(01)00811907030423(10)504670V70(17)211209
Combination Product (y/n)N
PMA/PMN Number
P180002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Remedial Action Patient Monitoring
Type of Report Initial
Report Date 05/29/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/09/2021
Device Model NumberZEPHYR 5.5-LP EBV
Device Catalogue NumberEBV-TS-5.5-LP
Device Lot Number504670-V7.0
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 05/29/2020
Initial Date FDA Received06/02/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/09/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age75 YR
-
-